Our symposium will showcase next-generation preclinical models for oncology and immunology, including organoids, ex vivo human tissues, humanized mouse models, and other innovative approaches.
These emerging technologies and methodologies offer remarkable benefits using cutting-edge models that complement traditional preclinical approaches, providing increased accuracy, personalized insights, accelerated drug discovery, and cost-efficiency.
Bringing together researchers and industry professionals, the symposium will enable you to engage with dynamic discussions and collaborations and help drive the successful implementation of these next-generation preclinical models in oncology and immunology research and drug discovery.
Join us for a full agenda of talks from the leading researchers in this rapidly developing area, followed by an opportunity to network with your peers at a complimentary drink’s reception
Attendance for the symposium is free but space is limited. We encourage early registration.
Lunch will be served.